Monkeypox slimulations to warnings of bioterrorism

Bavarian Nordic, the biotech company that makes the vaccine, has announced a $119 million order placed by the U.S., with the option to buy $180 million more if it wants. Should that second option be exercised, it would work out to approximately 13 million doses.

Nov 23, 2021
Strengthening Global Systems to Prevent and Respond to High-Consequence Biological Threats
Developed in consultation with technical and policy experts, the fictional exercise scenario portrayed a deadly, global pandemic involving an unusual strain of monkeypox virus that first emerged in the fictional nation of Brinia and spread globally over 18 months. Ultimately, the exercise scenario revealed that the initial outbreak was caused by a terrorist attack using a pathogen engineered in a laboratory with inadequate biosafety and biosecurity provisions and weak oversight. By the end of the exercise, the fictional pandemic resulted in more than three billion cases and 270 million fatalities worldwide.